Yuemei Hu

机构：Shanghai Jiao Tong University, Peking University, Peking University Third Hospital · ORCID：0000-0003-1827-4889

发表论文 109 篇 · 总被引 4875 次 · h-index 31

代表论文

• Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials (2022 · The Lancet Respiratory Medicine · 被引 145)
• Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial (2022 · The Lancet Infectious Diseases · 被引 93)
• Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response (2021 · Emerging Microbes & Infections · 被引 61)
• Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial (2023 · 中国科学通报：英文版 · 被引 28)
• Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials (2022 · Vaccine · 被引 25)
• Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study (2021 · The Lancet Regional Health - Western Pacific · 被引 24)